Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin

Diagnostic Microbiology and Infectious Disease

Volumn 74, Issue 4, 2012, Pages 412-414

  Sader, Helio S ^a   Rhomberg, Paul R ^a   Flamm, Robert K ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colistin; Polymyxin B; Polysorbate 80; Susceptibility tests

Indexed keywords

COLISTIN; POLYMYXIN B; POLYSORBATE 80;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; ESCHERICHIA COLI; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; COLISTIN; CULTURE MEDIA; ENTEROBACTERIACEAE; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B; POLYSORBATES; PSEUDOMONAS AERUGINOSA; SURFACE-ACTIVE AGENTS;

EID: 84869089999     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.08.025     Document Type: Article

References (12)

1. Arroyo L.A., Garcia-Curiel A., Pachon-Ibanez M.E., Llanos A.C., Ruiz M., Pachon J., et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii. J Clin Microbiol 2005, 43:903-905.
2. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition, M07-A9 2012, CLSI, Wayne, PA.
3. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing: 22nd informational supplement (M100-S22) 2012, CLSI, Wayne, PA.
4. EUCAST 2012 Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0, January 2012. Available at http://www.eucast.org/clinical_breakpoints/.
5. Gales A.C., Reis A.O., Jones R.N. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001, 39:183-190.
6. Gales A.C., Jones R.N., Sader H.S. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09). J Antimicrob Chemother 2011, 66:2070-2074.
7. Rennie R.P., Koeth L., Jones R.N., Fritsche T.R., Knapp C.C., Killian S.B., et al. Factors influencing broth microdilution antimicrobial susceptibility test results for dalbavancin, a new glycopeptide agent. J Clin Microbiol 2007, 45:3151-3154.
8. Sader H.S., Moet G.J., Rhomberg P.R., Fritsche T.R., Jones R.N. Analysis of the influence of surfactant (Tween-80) concentrations on susceptibility testing results for the polymyxins by broth microdilution methods 2006.
9. Sader H.S., Farrell D.J., Jones R.N. Susceptibility of Klebsiella spp. to colistin and polymyxin B: results from the SENTRY Antimicrobial Surveillance Program (2006-2009). Int J Antimicrob Agents 2011, 37:174-175.
10. Tan T.Y., Ng L.S. Comparison of three standardized disc susceptibility testing methods for colistin. J Antimicrob Chemother 2006, 58:864-867.
11. van der Heijden I.M., Levin A.S., De Pedri E.H., Fung L., Rossi F., Duboc G., et al. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins. Ann Clin Microbiol Antimicrob 2007, 6:8.
12. Zavascki A.P., Goldani L.Z., Li J., Nation R.L. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review. J Antimicrob Chemother 2007, 60:1206-1215.